ENOUGH
                                                                                                                                    
                                                                                                United Kingdom
                                                 -                                                 Glasgow, Scotland
                                                                                            
                                                                                    - 21/08/2023
 - Series C
 - $43,582,000
 
ENOUGHs purpose to ‘make protein sustainable’.  Using fermentation to meet future food protein needs is widely recognised as the most effective solution to feed a growing planet.  
ENOUGH produces ABUNDA® mycoprotein, a complete food ingredient containing all essential amino acids as well as being high in dietary fibre. It is versatile and can be made into alternative/vegan meat, seafood and dairy products.  The company will supply ABUNDA as a B2B (business to business) food ingredient to consumer brands and retailers, addressing the need for high scale supply of healthy and sustainable protein to address a rapidly growing market.  
The impact of introducing 1 million tonnes of ABUNDA mycoprotein by 2032 is equivalent to replacing 5 million cows, over a 1 billion chickens and reducing more than 5 million tonnes of CO2 emissions.
- Industry Biotechnology Research
 - Website https://www.enough-food.com/
 - LinkedIn https://www.linkedin.com/company/enough-food/about/
 
Related People
Jim LairdFounder
                                                    
                                                                                                                United Kingdom -
                                                         St. Albans, England
                                                    
                                                Highly experienced and entrepreneurial Commercial General Manager with a proven record of profit and value creation in a various sectors including FMCG, life science and technology development. 
Achieves results in roles including operations, strategy, change management, M&A and P&L management.
Specialties: Managing, building and getting the best out of teams:
• P&L Management - Sales Growth, Profit and Loss Management, Cost Out Management, Complexity reduction, International Sales
• Change Management - Programme Management, Business Integration, Strategic thinking, Strategic finance, Stakeholder management
• Team Development - Leadership skills, Team and culture development, Communication skills, Managing teams across several markets 
                                Vesence |  $9,000,000  | (Oct 30, 2025)
                            
                                Sparrow BioAcoustics |  $10,000,000  | (Oct 30, 2025)
                            
                                Reflectiz |  $22,000,000  | (Oct 30, 2025)
                            
                                    
                                    
                                    
                                    
                                    
                                            
                                                
                                                    
                                                    
                                                    
                                                    
                                                
                                                
                                                    
                                                
                                                    
                                                
                                                
                                                
                                                
                                                
                                                
                                                                        
                                Mem0 |  $24,000,000  | (Oct 30, 2025)
                                                                        
                                Valthos |  $30,000,000  | (Oct 30, 2025)
                                                                        
                                Mondra |  $13,206,500  | (Oct 30, 2025)
                                                                        
                                hoop.dev |  Undisclosed Amount  | (Oct 30, 2025)
                                                                        
                                IORGANBIO |  $2,000,000  | (Oct 30, 2025)
                                                                        
                                FrontlineIQ |  $3,300,000  | (Oct 30, 2025)
                                                                        
                                Homecourt |  $8,000,000  | (Oct 30, 2025)
                                                                        
                                VentureMed Inc. |  $28,000,000  | (Oct 30, 2025)
                                                                        
                                Recess |  $30,000,000  | (Oct 30, 2025)